Literature DB >> 12073014

FISH-mapping of a 100-kb terminal 22q13 deletion.

Britt-Marie Anderlid1, Jacqueline Schoumans, Göran Annerén, Isabel Tapia-Paez, Jan Dumanski, Elisabeth Blennow, Magnus Nordenskjöld.   

Abstract

Both cytogenetically visible and cryptic deletions of the terminal region of chromosome 22q are associated with a clinical phenotype including mental retardation, delay in expressive speech development, hypotonia, normal to accelerated growth and minor facial dysmorphic features. The genes responsible for the development of the phenotype have not yet been identified, but a distal localization is probable, since the cytogenetically visible and the cryptic deletions show a similar pattern of symptoms. We report a 33-year-old woman with a submicroscopic 22q13 deletion, mild mental retardation, speech delay, autistic symptoms and mild facial dysmorphic features. The deletion was mapped by FISH using cosmid probes from terminal 22q13, and the size of the deletion was estimated to be 100 kb. Three genes are affected by the deletion in this patient. ACR and RABL2B are deleted and proSAP2 is disrupted. This observation, together with recently published data, supports the notion that proSAP2 is the most important contributor to the 22q13 deletion phenotype.

Entities:  

Mesh:

Year:  2002        PMID: 12073014     DOI: 10.1007/s00439-002-0713-7

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  26 in total

1.  Characterizing regression in Phelan McDermid Syndrome (22q13 deletion syndrome).

Authors:  Gillian Reierson; Jon Bernstein; Wendy Froehlich-Santino; Alexander Urban; Carolin Purmann; Sean Berquist; Josh Jordan; Ruth O'Hara; Joachim Hallmayer
Journal:  J Psychiatr Res       Date:  2017-03-16       Impact factor: 4.791

2.  USP8 Deubiquitinates SHANK3 to Control Synapse Density and SHANK3 Activity-Dependent Protein Levels.

Authors:  Meghan Kerrisk Campbell; Morgan Sheng
Journal:  J Neurosci       Date:  2018-05-07       Impact factor: 6.167

Review 3.  Phelan-McDermid Syndrome and SHANK3: Implications for Treatment.

Authors:  Jesse L Costales; Alexander Kolevzon
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

4.  22q13.3 deletion syndrome: clinical and molecular analysis using array CGH.

Authors:  S U Dhar; D del Gaudio; J R German; S U Peters; Z Ou; P I Bader; J S Berg; M Blazo; C W Brown; B H Graham; T A Grebe; S Lalani; M Irons; S Sparagana; M Williams; J A Phillips; A L Beaudet; P Stankiewicz; A Patel; S W Cheung; T Sahoo
Journal:  Am J Med Genet A       Date:  2010-03       Impact factor: 2.802

5.  Clinical and genomic evaluation of 201 patients with Phelan-McDermid syndrome.

Authors:  Sara M Sarasua; Luigi Boccuto; Julia L Sharp; Alka Dwivedi; Chin-Fu Chen; Jonathan D Rollins; R Curtis Rogers; Katy Phelan; Barbara R DuPont
Journal:  Hum Genet       Date:  2014-01-31       Impact factor: 4.132

6.  Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3.

Authors:  Xiaoming Wang; Portia A McCoy; Ramona M Rodriguiz; Yanzhen Pan; H Shawn Je; Adam C Roberts; Caroline J Kim; Janet Berrios; Jennifer S Colvin; Danielle Bousquet-Moore; Isabel Lorenzo; Gangyi Wu; Richard J Weinberg; Michael D Ehlers; Benjamin D Philpot; Arthur L Beaudet; William C Wetsel; Yong-Hui Jiang
Journal:  Hum Mol Genet       Date:  2011-05-10       Impact factor: 6.150

Review 7.  Modeling autism by SHANK gene mutations in mice.

Authors:  Yong-Hui Jiang; Michael D Ehlers
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

8.  Submicroscopic subtelomeric aberrations in Chinese patients with unexplained developmental delay/mental retardation.

Authors:  Ye Wu; Taoyun Ji; Jingmin Wang; Jing Xiao; Huifang Wang; Jie Li; Zhijie Gao; Yanling Yang; Bin Cai; Liwen Wang; Zhongshu Zhou; Lili Tian; Xiaozhu Wang; Nan Zhong; Jiong Qin; Xiru Wu; Yuwu Jiang
Journal:  BMC Med Genet       Date:  2010-05-11       Impact factor: 2.103

9.  Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms.

Authors:  H L Wilson; A C C Wong; S R Shaw; W-Y Tse; G A Stapleton; M C Phelan; S Hu; J Marshall; H E McDermid
Journal:  J Med Genet       Date:  2003-08       Impact factor: 6.318

10.  Copy number variation and association analysis of SHANK3 as a candidate gene for autism in the IMGSAC collection.

Authors:  Nuala H Sykes; Claudio Toma; Natalie Wilson; Emanuela V Volpi; Inês Sousa; Alistair T Pagnamenta; Raffaella Tancredi; Agatino Battaglia; Elena Maestrini; Anthony J Bailey; Anthony P Monaco
Journal:  Eur J Hum Genet       Date:  2009-04-22       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.